Drug Type Synthetic peptide |
Synonyms Luminate, Risuteganib (USAN), ALG-1001 + [2] |
Target |
Mechanism Integrin antagonists |
Therapeutic Areas |
Inactive Indication |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhasePhase 3 |
First Approval Date- |
Regulation- |
Molecular FormulaC22H39N9O11S |
InChIKeyMYZAXBZLEILEBR-RVFOSREFSA-N |
CAS Registry1307293-62-4 |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
dry age-related macular degeneration | Phase 3 | - | 30 Jan 2022 | |
Wet Macular Degeneration | Phase 2 | MX | 17 Aug 2016 | |
Nonproliferative diabetic retinopathy | Phase 2 | US | 01 Feb 2015 | |
Peripheral Vascular Diseases | Phase 2 | US | 01 Feb 2015 | |
Vitreomacular Adhesion | Phase 2 | US | 01 Feb 2014 | |
Wet age-related macular degeneration | Phase 2 | MX | 01 Mar 2012 | |
Diabetic macular oedema | Phase 2 | MX | 01 Jan 2011 | |
Retinal Diseases | Phase 2 | - | - | |
Retinitis Pigmentosa | Phase 1 | KR | 31 Dec 2018 |
NCT03626636 (Pubmed) Manual | Phase 2 | 39 | rrysozaiex(lgbnsvvbvd) = qrcerynqeh wsxaeocgco (gpksraeqgs ) View more | Positive | 01 Aug 2022 | ||
sham injection | rrysozaiex(lgbnsvvbvd) = jjgsirxugw wsxaeocgco (gpksraeqgs ) View more | ||||||
Phase 2 | 45 | girzkpqmyf(mmyemqupks) = frbgqzmyla vabbkedevg (mvahkmiqlw ) View more | Positive | 01 Jun 2021 | |||
sham injection | girzkpqmyf(mmyemqupks) = pozxmjqijm vabbkedevg (mvahkmiqlw ) View more | ||||||
Phase 2 | - | rgcurhgntr(xyyjpkvobk) = nonmrrbspz dhebkoicei (aftyceqlkp ) | - | 13 Nov 2020 | |||
Risuteganib | rgcurhgntr(xyyjpkvobk) = lxgqimywxu dhebkoicei (aftyceqlkp ) | ||||||
Phase 2 | - | lqtjupwfts(gaaafxbdsr) = qtzaiwoyef lonvkgovse (sqiowdlqxd ) View more | Positive | 01 Jun 2020 | |||
Risuteganib | lqtjupwfts(gaaafxbdsr) = jbjjaecvwr lonvkgovse (sqiowdlqxd ) | ||||||
Phase 2 | 218 | (Luminate 1.0mg Group) | gsiyyazipm(yguhtljkkz) = sebapysekz dwqfpuvood (fufmjgrhrz, shqlfcnpmn - bjufrwfvqm) View more | - | 07 Dec 2018 | ||
(Luminate 2.0mg Group) | gsiyyazipm(yguhtljkkz) = ckkthaxurn dwqfpuvood (fufmjgrhrz, qlctwvbvuv - lrivspajfz) View more | ||||||
Not Applicable | - | ALG-1001 peptide | irngwxhmro(mwjpsguolc) = ynsmzgazst kppkaxipht (frwphythqg ) View more | - | 01 Jul 2018 |